NBPAS: The Alternative to the ABIM MOC
Dr. Paul Teirstein, President of NBPAS.org, joins me on Healthcare Unfiltered to highlight and reveal how the National Board of Physicians and Surgeons (NBPA…
Dr. Paul Teirstein, President of NBPAS.org, joins me on Healthcare Unfiltered to highlight and reveal how the National Board of Physicians and Surgeons (NBPA…
View Full-Length Video at: https://youtu.be/MquzOMGDI8kRelated Article Available at: https://mayocl.in/3JaDmRx
Researchers say MRI scans can more accurately detect heart disease in women, leading to earlier diagnosis and more effective treatments
In Europe, 1.55 million people die every year due to a poor diet. This is the conclusion of a recent study by Friedrich Schiller University…
The HFSA HF-Cert Bootcamp OnDemand is a comprehensive virtual program designed to prepare healthcare professionals for the HFSA HF-Cert examination
The primary end point of the analysis of cohort B was 12-month disease-free survival.
Neoadjuvant nivolumab plus chemotherapy is standard therapy for resectable non–small-cell lung cancer. Whether the addition of adjuvant nivolumab may improve…
In 2022, Outright International launched the Alliance for Global Equality (Alliance), a unique five-year collaboration led by Outright in partnership with the Victory Institute to…
Using the HER2DX genomic tool is feasible and effective in a real-world setting of patients with early-stage HER2-positive breast cancer.
Breast cancer survivors have a modestly increased risk of type 2 diabetes, largely driven by breast cancer treatment modalities.
Breast cancer survivors with metabolic syndrome have shorter disease-free survival than those without metabolic syndrome.